NDC 64764-107 – Entyvio
Vedolizumab 108 mg/.68mL · Injection, Solution · Subcutaneous
Product NDC64764-107
Product details
- Brand name
- Entyvio
- Generic name
- vedolizumab
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761133
- Marketed since
- September 27, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Integrin Receptor Antagonist
Active ingredients
- Vedolizumab 108 mg/.68mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 64764-107-11 | 1 TRAY in 1 CARTON (64764-107-11) / 1 SYRINGE in 1 TRAY (64764-107-10) / .68 mL in 1 SYRINGE | Sep 27, 2023 |
Other Entyvio products
- 64764-300 Vedolizumab 300 mg/5mL · Injection, Powder, Lyophilized, For Solution · Takeda Pharmaceuticals America, Inc.